Maximising Outcome by Overcoming Depression in Stroke Trial "MOODS"

Suspended

Phase N/A Results

Summary of Purpose

To determine the benefits and risks of fluoxetine and omega-3 fatty acids in patients with symptoms of post-stroke depression

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, factorial, double-blind, placebo-controlled, multi-center trial.

Contacts

Not available